Skip to main content
SpringerLink
Log in

Pharmacogenomics: The implementation phase

  • Published:
AAPS PharmSci Aims and scope Submit manuscript

Abstract

Pharmacogenomics makes use of genetic and genomic principles to facilitate drug discovery and development, and to improve drug therapy. Its goal is to attain optimal therapy for the individual patient. This article analyzes current trends in pharmacogenomics and asks how this new science affects drug development in the pharmaceutical industry and the clinical use of drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sadee W. Pharmacogenomics. Brit. Med. J. 1999;319:1286 Available at http://www.pmj.com/cgi/content/full/319/7220/1286?maxtoshow=&HITS=10&hlt

    Article  PubMed Central  Google Scholar 

  2. Evans WE, Relling MV. Pharmacogenomics: translating functional genomics into rational therapeutics. Science 1999;286:487–491.

    Article  CAS  PubMed  Google Scholar 

  3. Mancinelli L, Cronin M, Sadee W. Pharmacogenomics: The promise of personalized medicine. AAPS Pharm Sci 2000;2 (1) article 4. Available http://www.pharmsci.org/scientificjournals/pharmsci/journal/4.html

  4. Johnson JA. Drug targe pharmacogenomics. Am J Pharmacogenomics. 2001;1:271–281.

    Article  CAS  PubMed  Google Scholar 

  5. Tolle R. Information technology tools for efficient SNP studies. Am J Pharmacogenomics 2001;1:303–314.

    Article  CAS  PubMed  Google Scholar 

  6. Cambien F, Poirier O, Nicaud V, et al. Sequence diversity in 36 candidate genes for cardiovascular disease. Am J Hum Genet. 1999;65:183–191.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Phillips KA, Veenstra D, Sadee W. Implications of the genetic revolution for health services research: Pharmacogenomics and improvements in drug therapy. Health Serv Res. 2000;35:128–140.

    CAS  PubMed Central  PubMed  Google Scholar 

  8. Krynetsky EY, Evans WE. Pharmacogenetics of cancer therapy: getting personal. Am J Hum Genet. 1998;63:11–16.

    Article  Google Scholar 

  9. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients. JAMA. 1998;279:1200–1205.

    Article  CAS  PubMed  Google Scholar 

  10. Phillips KA, Veenstra DL, Oren E, Lee K, Sadee W. The potential role of pharmacogenomics in reducing adverse drug reactions: A systematic review. JAMA. 2001; 286:2270–2279.

    Article  CAS  PubMed  Google Scholar 

  11. Kuivenhoven JA, Jukema JW, Zwinderman AH, et al. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. NEJM. 1998;338:86–93.

    Article  CAS  PubMed  Google Scholar 

  12. Drysdale CM, McGraw DW, Stack CB, et al. Complex promoter and coding region beta2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. PNAS. 2000;97:10483–10488.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Arranz MJ, Munro J, Birkett J, et al. Pharmacogenetic prediction of clozapine response. Lancet. 2000;355:1615–1616.

    Article  CAS  PubMed  Google Scholar 

  14. Reich DE, Cargill M, Bolk S, et al. Linkage disequilibrium in the human genome. Nature. 2000;411:199–204.

    Article  Google Scholar 

  15. Patil N, Berno AJ, Hinds DA, et al. Blocks of limited haplotype diversity revealed by high resolution scanning of human chromosome 21. Science. 2001;294:1719–1723.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Medicine and Public Health, Ohio State University, 043210-1239, Columbus, OH

    Wolfgang Sadee

Authors
  1. Wolfgang Sadee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wolfgang Sadee.

Additional information

Published: April 1, 2002

This article also appears in AAPS Newsmagazine, April 2002;5(4)-17,33-35.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sadee, W. Pharmacogenomics: The implementation phase. AAPS PharmSci 4, 5 (2002). https://doi.org/10.1208/ps040210

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1208/ps040210

Keywords

Search

Navigation